Download PDF
Previous article
Go back to website
If you have problems to see the content please click here
Other users also viewed these articles
NSAIDs, gastrointestinal toxicity and inflammatory bowel disease
Gonzalo Hijos-Mallada; Carlos Sostres; Fernando Gomollón;
Gastroenterol Hepatol. 2022;45:215-22
Characterization and prevalence of extraintestinal manifestations in a cohort of patients with inflammatory intestinal disease in Medellin, Colombia
Fabián Juliao-Baños; Mateo Arrubla; Laura Osorio; Joselyn Camargo; Juliana Londoño; Camilo Cáceres; Jhon Carvajal; Gabriel Mosquera-Klinger; Jorge Donado;
Gastroenterol Hepatol. 2021;44:398-404
Headache in patients with inflammatory bowel disease: Migraine prevalence according to the Migraine Screening-Questionnaire (MS-Q) and headache characteristics
Alicia Gonzalez-Martinez; Inés Muro; Sonia Quintas; María Chaparro; Javier P. Gisbert; Ancor Sanz-García; María José Casanova; Cristina Rubín de Célix; José Vivancos; Ana Beatriz Gago-Veiga;
Gastroenterol Hepatol. 2024;47:63-71